NCT03678883 2024-11-07
9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
Celgene
ETOP IBCSG Partners Foundation
Grupo Espanol de Investigacion en Sarcomas
Novartis
University of Pittsburgh
GERCOR - Multidisciplinary Oncology Cooperative Group
Hellenic Oncology Research Group
Southeastern Gynecologic Oncology